Min Yan

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Min Yan

Nov 30, 2024, 23:26 | Insight

Is Carboplatin needed for the neoadjuvant treatment of HER2 positive Breast cancer?

Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a recent by Xiu-Chun Chen on…

Oct 4, 2024, 15:09 | Blog

Phase 3 EVER-002 trial is out

Paolo Tarantino shared an article by Binghe Xu on X: "Phase 3 EVER-002 trial (also…

Sep 19, 2024, 16:25 | Insight

Razelle Kurzrock: What’s old is new again

Razelle Kurzrock shared a post on X: "What’s old is new again!! Her2 expression across cancers…

Jun 15, 2024, 04:45 | Blog

Discover the latest advancements in treating HER2-negative breast cancer brain metastases - Media Medic

Media Medic shared a post on LinkedIn: "ASCO China Voice | Professor Min Yan: Utidelone…

All: 4 Posts: 1 - 100

'

Who From Oncology is Featured in TIME100 Health 2025?

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023